| Literature DB >> 30486457 |
Perot Saelao1,2,3, Ying Wang4,5, Ganrea Chanthavixay6,7,8, Vivian Yu9, Rodrigo A Gallardo10, Jack C M Dekkers11, Susan J Lamont12, Terra Kelly13,14, Huaijun Zhou15,16.
Abstract
: Newcastle disease virus (NDV) is a devastating worldwide poultry pathogen with major implications for global food security. In this study, two highly inbred and genetically distinct chicken lines, Fayoumis and Leghorns, were exposed to a lentogenic strain of NDV, while under the effects of heat stress, in order to understand the genetic mechanisms of resistance during high ambient temperatures. Fayoumis, which are relatively more resistant to pathogens than Leghorns, had larger numbers of differentially expressed genes (DEGs) during the early stages of infection when compared to Leghorns and subsequently down-regulated their immune response at the latter stages to return to homeostasis. Leghorns had very few DEGs across all observed time points, with the majority of DEGs involved with metabolic and glucose-related functions. Proteomic analysis corroborates findings made within Leghorns, while also identifying interesting candidate genes missed by expression profiling. Poor correlation between changes observed in the proteomic and transcriptomic datasets highlights the potential importance of integrative approaches to understand the mechanisms of disease response. Overall, this study provides novel insights into global protein and expression profiles of these two genetic lines, and provides potential genetic targets involved with NDV resistance during heat stress in poultry.Entities:
Keywords: Newcastle disease virus; RNA-seq; chicken; proteomics
Year: 2018 PMID: 30486457 PMCID: PMC6316021 DOI: 10.3390/genes9120579
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Number of differentially expressed genes (DEGs) and differentially abundant proteins (DAPs) in Fayoumis and Leghorns at each timepoint with a false discovery rate (FDR) < 0.05.
|
|
| ||||
|---|---|---|---|---|---|
|
| Days Post-Infection | Up-Regulated | Down-Regulated | Up-Regulated | Down-Regulated |
|
| 2 | 122 | 58 | 0 | 6 |
|
| 2 | 35 | 2 | 5 | 5 |
|
| 6 | 26 | 27 | 4 | 9 |
|
| 6 | 6 | 1 | 62 | 37 |
|
| 10 | 173 | 358 | ||
|
| 10 | 10 | 5 | ||
Figure 1Significantly enriched pathways identified through the Ingenuity Pathway Analysis among the differentially expressed genes by timepoint and genetic line. (A) Fayoumi at 2 days post-infection (dpi), (B) Leghorn at 2 dpi, (C) Fayoumi at 6 dpi, (D) Leghorn at 6 dpi, (E) Fayoumi at 10 dpi, and (F) Leghorn at 10 dpi. The number of genes in each pathway is shown in black, up-regulated (red) and down-regulated genes (green) within the pathway, and the significance value calculated as the −log(p-value) is depicted as an orange line.
Top canonical pathways significantly enriched between treated and non-treated Fayoumis at 10 dpi. Activated pathways are Z-score > 0 and inhibited pathways are Z-score < 0. NA designates pathways without a predicted activity score.
| Canonical Pathway | Z-Score |
|---|---|
| ERK/MAPK Signaling | −2.24 |
| Thrombin Signaling | −2.24 |
| mTOR Signaling | −2.00 |
| Fcy Receptor-mediated Phagocytosis in Macrophages and Monocytes | −2.00 |
| p70S6K Signaling | −1.89 |
| B Cell Receptor Signaling | −1.89 |
| Colorectal Cancer Metastasis Signaling | −1.89 |
| Mouse Embryonic Stem Cell Pluripotency | −1.63 |
| Rac Signaling | −1.34 |
| Ga12/13 Signaling | −1.34 |
| IL-8 Signaling | −1.34 |
| NF-kappaB Signaling | −1.34 |
| Regulation of eIF4 and p70S6K Signaling | −1.34 |
| NGF Signaling | −1.34 |
| Telomerase Signaling | −1.34 |
| Acute Myeloid Leukemia Signaling | −1.34 |
| Fc Epsilon RI Signaling | −1.00 |
| fMLP Signaling in Neutrophils | −1.00 |
| ErbB Signaling | −1.00 |
| Growth Hormone Signaling | −1.00 |
| EIF2 Signaling | −1.00 |
| FLT3 Signaling in Hematopoietic Progenitor Cells | −1.00 |
| Melanocyte Development and Pigmentation Signaling | −1.00 |
| Renal Cell Carcinoma Signaling | −1.00 |
| Neuregulin Signaling | −1.00 |
| Insulin Receptor Signaling | −1.00 |
| GM-CSF Signaling | −1.00 |
| Sirtuin Signaling Pathway | −0.45 |
| Prolactin Signaling | 0.00 |
| PTEN Signaling | 0.00 |
| Neuroinflammation Signaling Pathway | 0.45 |
| AMPK Signaling | NA |
| G Beta Gamma Signaling | NA |
| FcyRIIB Signaling in B Lymphocytes | NA |
| Renin-Angiotensin Signaling | NA |
| Role of NFAT in Cardiac Hypertrophy | NA |
| eNOS Signaling | NA |
| Huntington’s Disease Signaling | NA |
| GP6 Signaling Pathway | NA |
| ErbB4 Signaling | NA |
| Lymphotoxin B Receptor Signaling | NA |
| PAK Signaling | NA |
| CD40 Signaling | NA |
| Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | NA |
| alpha-Adrenergic Signaling | NA |
| P2Y Purigenic Receptor Signaling Pathway | NA |
| Amyotrophic Lateral Sclerosis Signaling | NA |
Figure 2STRING network analysis on DAPs between treated and non-treated Leghorns at 6 dpi. Nodes depict protein-protein interactions. Figure table lists the significantly enriched pathways and their corresponding differentially abundant protein within these pathways.
Correlation coefficients and p-value statistics calculated between the log2(fold change) in gene expression and the log2(fold change) in protein abundance between treated and non-treated birds at each timepoint.
|
|
|
| |
|---|---|---|---|
|
| 2 | −0.0072 | 0.86 |
|
| 2 | −0.053 | 0.22 |
|
| 6 | 0.051 | 0.22 |
|
| 6 | −0.018 | 0.65 |
Figure 3Correlation between the log2(fold change) in gene expression and the log2(fold change) in protein abundance between treated and non-treated birds at each timepoint. Intensity of each point represents the q-score of the gene.